O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Louis A. Weiss Memorial Hospital
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Illinois at Chicago Health Sciences Center
Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Evanston Northwestern Health Care
Evanston, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Lutheran General Cancer Care Center
Park Ridge, Illinois, United States
- Oncology/hematology Associates of Central Illinois, P.C.
Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology, Incorporated
Fort Wayne, Indiana, United States
- Michiana Hematology/oncology P.C.
South Bend, Indiana, United States
- Mercy Ireland Cancer Center
Canton, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2000
- Primary completion
- 31 Dec 2005
- Completion
- —
- Last update posted
- 11 Feb 2013
- Registered enrollment
- 40
- Registry id
- NCT00005961
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.